Is FDG-PET suitable for evaluating neoadjuvant therapy in non-small cell lung cancer? Evidence with systematic review of the literature
Ángel C. Rebollo-Aguirre, Carlos Ramos-Font, Román Villegas Portero, Gary J.R. Cook, José Manuel Llamas Elvira, Antonio Romero TabaresVolume:
101
Year:
2010
Language:
english
Pages:
1
DOI:
10.1002/jso.21525
File:
PDF, 205 KB
english, 2010